📣 VC round data is live. Check it out!

Xiamen Comfort Science Valuation Multiples

Discover revenue and EBITDA valuation multiples for Xiamen Comfort Science and similar public comparables like Curves Holdings Co., Koshidaka Holdings, Cineplex, CJ CGV and more.

Xiamen Comfort Science Overview

About Xiamen Comfort Science

Xiamen Comfort Science and Technology Group Co Ltd is a China based company operating in the industries of health massage, health environment, home medical care, and others. The company is principally engaged in manufacturing massage healthcare product like massage chairs. It also offers products in the areas of healthy environment like humidifier, and health monitoring like weight analysis device. The company sells its products in China and other international countries. Some of the company's brands are Ogawa, Cozzia, Fuji, Fujimedic, and Medisana.


Founded

1996

HQ

China

Employees

N/A

Financials (LTM)

Revenue: $773M
EBITDA: $53M

EV

$452M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Xiamen Comfort Science Financials

Xiamen Comfort Science reported last 12-month revenue of $773M and EBITDA of $53M.

In the same LTM period, Xiamen Comfort Science generated $264M in gross profit, $53M in EBITDA, and $3M in net income.

Revenue (LTM)


Xiamen Comfort Science P&L

In the most recent fiscal year, Xiamen Comfort Science reported revenue of $749M and EBITDA of $51M.

Xiamen Comfort Science is profitable as of last fiscal year, with gross margin of 34%, EBITDA margin of 7%, and net margin of 0%.

See analyst estimates for Xiamen Comfort Science
LTMLast FY202320242025202620272028
Revenue$773M$749M$740M$711M$749M
Gross Profit$264M$254M$274M$256M$254M
Gross Margin34%34%37%36%34%
EBITDA$53M$51M$70M$60M$51M
EBITDA Margin7%7%9%8%7%
EBIT Margin(0%)1%4%2%1%
Net Profit$3M$2M$15M$9M$2M
Net Margin0%0%2%1%0%

Financial data powered by Morningstar, Inc.

Xiamen Comfort Science Stock Performance

Xiamen Comfort Science has current market cap of $493M, and enterprise value of $452M.

Market Cap Evolution


Xiamen Comfort Science's stock price is $0.79.

Xiamen Comfort Science share price decreased by 6.2% in the last 30 days, and by 16.4% in the last year.

See more trading valuation data for Xiamen Comfort Science
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$452M$493M0.3%-6.2%-23.8%-16.4%$0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Xiamen Comfort Science Valuation Multiples

Xiamen Comfort Science trades at 0.6x EV/Revenue multiple, and 8.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Xiamen Comfort Science

EV / Revenue (LTM)


Xiamen Comfort Science Financial Valuation Multiples

As of May 26, 2026, Xiamen Comfort Science has market cap of $493M and EV of $452M.

Xiamen Comfort Science has a P/E ratio of 145.6x.

LTMLast FY202320242025202620272028
EV/Revenue0.6x0.6x0.6x0.6x0.6x
EV/EBITDA8.5x8.9x6.4x7.5x8.9x
EV/EBITn/m72.4x14.5x34.6x72.4x
EV/Gross Profit1.7x1.8x1.6x1.8x1.8x
P/E145.6xn/m32.5x52.1xn/m
EV/FCF—(14.6x)4.7x(34.0x)(14.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Xiamen Comfort Science Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Xiamen Comfort Science Margins & Growth Rates

Xiamen Comfort Science grew revenue by 9% and EBITDA by 16% in the last fiscal year.

In the most recent fiscal year, Xiamen Comfort Science reported gross margin of 34%, EBITDA margin of 7%, and net margin of 0%.

See estimated margins and future growth rates for Xiamen Comfort Science

Xiamen Comfort Science Margins

Last FY202420252026202720282029
Gross Margin34%36%34%34%
EBITDA Margin7%8%7%7%
EBIT Margin1%2%1%1%
Net Margin0%1%0%1%
FCF Margin(4%)(2%)(4%)—

Xiamen Comfort Science Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth9%(4%)5%9%
Gross Profit Growth10%(7%)(1%)10%
EBITDA Growth16%(14%)(16%)16%
EBIT Growth51%(58%)(52%)51%
Net Profit Growth219%(38%)(81%)219%
FCF Growth—(114%)132%—

Data powered by FactSet, Inc. and Morningstar, Inc.

Xiamen Comfort Science Operational KPIs

Xiamen Comfort Science's Rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Xiamen Comfort Science's Rule of X is 29% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Xiamen Comfort Science
LTMLast FY202320242025202620272028
Rule of 4016%16%———
Bessemer Rule of X29%29%———
S&M Expenses to Revenue—9%9%9%9%
G&A Expenses to Revenue8%8%3%3%2%
R&D Expenses to Revenue—4%4%5%4%
Opex to Revenue—33%33%34%33%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Xiamen Comfort Science Competitors

Xiamen Comfort Science competitors include Curves Holdings Co., Koshidaka Holdings, Cineplex, CJ CGV, Cinema XXI, Armah Sports, ClubLink, Marcus, Tivoli and The Gym Group.

Most Xiamen Comfort Science public comparables operate across Lifestyle & Recreation.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Curves Holdings Co.1.9x1.8x8.1x7.6x
Koshidaka Holdings1.2x1.1x5.0x5.0x
Cineplex1.8x1.8x9.3x8.6x
CJ CGV1.1x1.1x6.5x6.8x
Cinema XXI1.3x1.3x4.1x4.5x
Armah Sports10.3x—17.8x—
ClubLink1.9x—7.2x—
Marcus1.2x1.2x9.0x8.5x

This data is available for Pro users. Sign up to see all Xiamen Comfort Science competitors and their valuation data.

Start Free Trial

Xiamen Comfort Science Investment Activity

Xiamen Comfort Science has invested in 1 company to date.

Latest investment by Xiamen Comfort Science was on December 22nd 2017. Xiamen Comfort Science invested in LeFan in their $500K Angel round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Xiamen Comfort Science

LeFan
Description
LeFan is a Chinese manufacturer of intelligent massage chairs equipped with AI-driven features. Based in Shenzhen, the company produces models with zero-gravity positioning, SL-track rollers, and voice control, distributed through retail chains in Asia and North America. LeFan's chairs incorporate heat therapy and airbag compression for full-body relaxation.
HQ CountryChina
HQ City
Xiamen
Deal Date22 Dec 2017
RoundAngel
Raised$500K
InvestorsXiamen Comfort Science
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Xiamen Comfort Science investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Xiamen Comfort Science

When was Xiamen Comfort Science founded?Xiamen Comfort Science was founded in 1996.
Where is Xiamen Comfort Science headquartered?Xiamen Comfort Science is headquartered in China.
Is Xiamen Comfort Science publicly listed?Yes, Xiamen Comfort Science is a public company listed on Shenzhen Stock Exchange.
What is the stock symbol of Xiamen Comfort Science?Xiamen Comfort Science trades under 002614 ticker.
When did Xiamen Comfort Science go public?Xiamen Comfort Science went public in 2011.
Who are competitors of Xiamen Comfort Science?Xiamen Comfort Science main competitors include Curves Holdings Co., Koshidaka Holdings, Cineplex, CJ CGV, Cinema XXI, Armah Sports, ClubLink, Marcus, Tivoli, The Gym Group.
What is the current market cap of Xiamen Comfort Science?Xiamen Comfort Science's current market cap is $493M.
What is the current revenue of Xiamen Comfort Science?Xiamen Comfort Science's last 12 months revenue is $773M.
What is the current revenue growth of Xiamen Comfort Science?Xiamen Comfort Science revenue growth (NTM/LTM) is 9%.
What is the current EV/Revenue multiple of Xiamen Comfort Science?Current revenue multiple of Xiamen Comfort Science is 0.6x.
Is Xiamen Comfort Science profitable?Yes, Xiamen Comfort Science is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Xiamen Comfort Science?Xiamen Comfort Science's last 12 months EBITDA is $53M.
What is Xiamen Comfort Science's EBITDA margin?Xiamen Comfort Science's last 12 months EBITDA margin is 7%.
What is the current EV/EBITDA multiple of Xiamen Comfort Science?Current EBITDA multiple of Xiamen Comfort Science is 8.5x.
How many companies Xiamen Comfort Science has acquired to date?Xiamen Comfort Science hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Xiamen Comfort Science has invested to date?As of May 2026, Xiamen Comfort Science has invested in 1 company.
What was the last Xiamen Comfort Science investment?On 22nd December 2017 Xiamen Comfort Science invested in LeFan, participating in a $500K Angel round.
In what companies Xiamen Comfort Science invested in?Xiamen Comfort Science invested in LeFan.

See public comps similar to Xiamen Comfort Science

Lists including Xiamen Comfort Science

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial